Castanon E, Sanchez-Arraez A, Jimenez-Fonseca P, Alvarez-Mancenido F, Martinez-Martinez I, Mihic Gongora L, Carmona-Bayonas A. Bayesian interpretation of immunotherapy trials with dynamic treatment effects. Eur J Cancer. 2022 Jan;161:79-89. doi: 10.1016/j.ejca.2021.11.002. Epub 2021 Dec 18. PubMed PMID: 34933154.
AÑO: 2022; IF: 8.4
|
Jimenez-Fonseca P, Salazar R, Valenti V, Msaouel P, Carmona-Bayonas A. Is short-course radiotherapy and total neoadjuvant therapy the new standard of care in locally advanced rectal cancer? A sensitivity analysis of the RAPIDO clinical trial. Ann Oncol. 2022 Aug;33(8):786-793. doi: 10.1016/j.annonc.2022.04.010. Epub 2022 Apr 22. PubMed PMID: 35462008.
AÑO: 2022; IF: 50.5
|
Vicente Conesa MA, Zafra Poves M, Carmona-Bayonas A, Ballester Navarro I, de la Morena Barrio P, Ivars Rubio A, Montenegro Luis S, Garcia Garre E, Vicente V, Ayala de la Pena F. A prognostic model to identify short survival expectancy of medical oncology patients at the time of hospital discharge. ESMO Open. 2022 Feb;7(1):100384. doi: 10.1016/j.esmoop.2022.100384. Epub 2022 Feb 7. PubMed PMID: 35144121; PubMed Central PMCID: PMC8844687.
AÑO: 2022; IF: 6.883
|
Velasco-Durantez V, Jimenez-Fonseca P, Martin Abreu CM, Ghanem I, Gonzalez Moya M, Asensio E, Corral MJ, Rodriguez-Gonzalez A, Gil-Raga M, Carmona-Bayonas A, Calderon C. Resilience, Social Support, and Anxious Preoccupation in Patients with Advanced Cancer during COVID-19 Pandemic. Cancer Invest. 2022 Jul;40(6):475-482. doi: 10.1080/07357907.2022.2067864. Epub 2022 May 3. PubMed PMID: 35468046.
AÑO: 2022; IF: 2.4
|
Zaragoza-Huesca D, Nieto-Olivares A, Garcia-Molina F, Ricote G, Montenegro S, Sanchez-Canovas M, Garrido-Rodriguez P, Penas-Martinez J, Vicente V, Martinez F, Lozano ML, Carmona-Bayonas A, Martinez-Martinez I. Implication of Hepsin from Primary Tumor in the Prognosis of Colorectal Cancer Patients. Cancers (Basel). 2022 Jun 24;14(13):3106. doi: 10.3390/cancers14133106. PubMed PMID: 35804878; PubMed Central PMCID: PMC9264764.
AÑO: 2022; IF: 6.575
|